MedTrace Logo

Machine Perfusion in High vs Low/Mid-volume Liver Transplant Centers: a Multicentre Survey

NCT05662969 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 67

Last updated 2022-12-23

No results posted yet for this study

Summary

Introduction: Machine perfusion (MP) was developed to expand the available donor pool and to improve liver transplantation outcomes. Despite optimal results in clinical trials, MP benefit outside of clinical experimentation in unknown. Low/mid volume centres (L/MVCs) may face logistical/economical difficulties that may in turn hamper optimal MP results.

Methods: An Online 22-item survey on the use of machine perfusion for liver transplantation outside of clinical trials, was distributed to worldwide LT centres representatives. Variables of interest included MP logistics, MP technicalities, MP results, post-MP LT results. Responding centres were grouped into high volume centre (HVCs)(defined as \>60 LTs per year in 2019) and L/MVCs. Results from HVCs vs L/MVCs were compared.

Conditions

  • Organ Preservation Solution

Interventions

DEVICE

MACHINE PERFUSION

Different outcomes of MP use in low/mid-volume and high-volume LT centres

Sponsors & Collaborators

  • Roberta Angelico

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-31
Primary Completion
2022-01-31
Completion
2022-03-31
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05662969 on ClinicalTrials.gov